Used primarily in pharmaceutical research, (S)-6,7-Difluorochroman-4-amine serves as a key intermediate in the synthesis of biologically active compounds. Its structure is particularly valuable in the development of central nervous system (CNS) drugs, where it contributes to the creation of molecules targeting neurological disorders. Additionally, it is explored for its potential in designing selective enzyme inhibitors, which can be applied in treating conditions like depression or anxiety. The compound’s chiral nature also makes it useful in studies focusing on stereochemistry and drug efficacy.